Home

glaxosmithkline asthma inhaler

GSK seeks additional asthma indication for Trelegy Ellipta - MassDevice
GSK seeks additional asthma indication for Trelegy Ellipta - MassDevice

FDA Committees Recommend Approval of Breo Ellipta for Adult Asthma, but not  Adolescent | RT
FDA Committees Recommend Approval of Breo Ellipta for Adult Asthma, but not Adolescent | RT

ADVAIR homepage | ADVAIR (fluticasone propionate and salmeterol)
ADVAIR homepage | ADVAIR (fluticasone propionate and salmeterol)

Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die - Bloomberg
Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die - Bloomberg

What are the different types of inhalers? - My Pharmacy
What are the different types of inhalers? - My Pharmacy

GSK breathes freely as Mylan launches Advair generic in UK
GSK breathes freely as Mylan launches Advair generic in UK

GSK's Arnuity and Incruse Ellipta Available in US for Asthma and COPD  Patients | RT
GSK's Arnuity and Incruse Ellipta Available in US for Asthma and COPD Patients | RT

The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline​, is  pictured on white. The active ingredients in Breo are fluticasone and  vilanterol Stock Photo - Alamy
The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline​, is pictured on white. The active ingredients in Breo are fluticasone and vilanterol Stock Photo - Alamy

The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline​, is  pictured on white. The active ingredients in Breo are fluticasone and  vilanterol Stock Photo - Alamy
The BREO Ellipta metered asthma inhaler, made by GlaxoSmithKline​, is pictured on white. The active ingredients in Breo are fluticasone and vilanterol Stock Photo - Alamy

D Young & Co | The colour purple - no passing off in Glaxo v Sandoz
D Young & Co | The colour purple - no passing off in Glaxo v Sandoz

Breo Ellipta Now Approved as Asthma Treatment for Adult Patients in Canada
Breo Ellipta Now Approved as Asthma Treatment for Adult Patients in Canada

GlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after  asthma patients | Fierce Pharma
GlaxoSmithKline earns FDA nod for triple-drug combo Trelegy in sought-after asthma patients | Fierce Pharma

Manila Ph Feb 11 Gsk Seretide Stock Photo 1315895285 | Shutterstock
Manila Ph Feb 11 Gsk Seretide Stock Photo 1315895285 | Shutterstock

GSK Pharmaceuticals Ltd. Ventorlin Inhaler
GSK Pharmaceuticals Ltd. Ventorlin Inhaler

GlaxoSmithKline Recalls Ventolin Inhalers - Drug Company Announces  Nationwide Recall
GlaxoSmithKline Recalls Ventolin Inhalers - Drug Company Announces Nationwide Recall

Express Scripts rolls out smart inhalers in digital health push | Fierce  Biotech
Express Scripts rolls out smart inhalers in digital health push | Fierce Biotech

600,000 asthma inhalers recalled by GlaxoSmithKline - ABC7 Chicago
600,000 asthma inhalers recalled by GlaxoSmithKline - ABC7 Chicago

GSK expands its portfolio of medicines in the US for patients with asthma  and COPD
GSK expands its portfolio of medicines in the US for patients with asthma and COPD

Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler ( GlaxoSmithKline UK Ltd) 30 dose - RightBreathe
Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler ( GlaxoSmithKline UK Ltd) 30 dose - RightBreathe

FDA Approves GSK, Propeller Health's 'Smart Inhaler' - Research &  Development World
FDA Approves GSK, Propeller Health's 'Smart Inhaler' - Research & Development World

Asthma Inhaler And Spacer Galaxy S7 Case by Lewis Houghton/science Photo  Library - Pixels
Asthma Inhaler And Spacer Galaxy S7 Case by Lewis Houghton/science Photo Library - Pixels

GSK's Breo approved in Europe, COPD market may be underestimated - MM+M -  Medical Marketing and Media
GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media

Respiratory Inhaler Devices Market 2022 Global Competition
Respiratory Inhaler Devices Market 2022 Global Competition

Adherium wins US clearance for GSK inhaler users to connect to new platform
Adherium wins US clearance for GSK inhaler users to connect to new platform

GSK opens £56m Ellipta inhaler plant in the UK
GSK opens £56m Ellipta inhaler plant in the UK

590,000 Ventolin HFA 200D Albuterol Inhalers Recalled - Northeast Allergy,  Asthma, and Immunology
590,000 Ventolin HFA 200D Albuterol Inhalers Recalled - Northeast Allergy, Asthma, and Immunology

Asthma Inhaler Recall: Nearly 600,000 Inhalers Affected: Advanced Allergy  and Asthma: Allergists
Asthma Inhaler Recall: Nearly 600,000 Inhalers Affected: Advanced Allergy and Asthma: Allergists

Can Switching Inhalers Reduce Your Carbon Footprint? | MedPage Today
Can Switching Inhalers Reduce Your Carbon Footprint? | MedPage Today

GSK report finds dissatisfaction with asthma management
GSK report finds dissatisfaction with asthma management